HB 1881
In CommitteeHouse
Health care marketplace
Concerning material changes to the operations and governance structure of participants in the health care marketplace.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill strengthens state oversight of health care mergers and acquisitions to protect access, affordability, and equity of care—especially for reproductive, gender-affirming, and end-of-life services. It requires advance notice of major health care transactions and mandates a detailed review of their impact before approval, with ongoing monitoring for five years.
- Requires health care entities (hospitals, hospital systems, provider organizations, and certain insurers) to give 90 days’ advance notice to the attorney general and health care authority before completing mergers, acquisitions, or new contracting affiliations.
- Establishes a new access, affordability, quality, and equity review that assesses whether a transaction will maintain or improve access to care—including emergency, reproductive, gender-affirming, and end-of-life services—and reduce health disparities.
- Prohibits transactions that would reduce access to affordable care for at least five years, unless they meet specific public benefit criteria (e.g., maintain or improve care in underserved areas, reduce costs, or improve health outcomes).
- Requires a public hearing and mandates that the health care authority engage with community members, employees, and advocacy groups before making recommendations to the attorney general.
- Gives the attorney general authority to approve, approve with conditions, or deny a transaction—and to monitor compliance for up to five years, including through audits and annual reporting.
- Imposes civil penalties for noncompliance (up to 10% of transaction value) and allows the attorney general to seek injunctions or legal enforcement if a transaction proceeds without approval or violates conditions.
Who is affected
- Health care providers and systems — Hospitals, hospital systems, and provider organizations must submit detailed notices to state agencies before completing mergers, acquisitions, or new contracting affiliations, and may be subject to review, conditions, or denial of the transaction based on impacts to care access and affordability.
- Health insurers and third-party administrators — Insurance companies and health plans must be notified of certain transactions involving health care entities and may be impacted if a merger or affiliation changes how services are billed or delivered.
- Patients and community members — Patients—especially those in rural areas, low-income individuals, people of color, LGBTQ+ individuals, and those seeking reproductive, gender-affirming, or end-of-life care—may see changes in care availability, cost, or quality depending on how transactions are approved or restricted.
- State government agencies — State agencies—the attorney general and health care authority—gain new authority to review, approve (with conditions), or block health care transactions and monitor compliance for up to five years.
- Health care workers and unionized staff — Employees of affected health care organizations may face changes in staffing, working conditions, or benefits, and gain a formal role in providing input during the review process.
Pro/Con Analysis
Stronger case for concerns
Potential Benefits (2)
Exempts or simplifies review for small, safety-net providers (e.g., FQHCs, rural clinics, providers serving ≥50% Medicaid/uninsured patients), reducing regulatory burden on organizations most critical to equitable care access.
Business & EmploymentRef: Sec. 4(1), Sec. 4(2), Sec. 15Requires 5-year post-transaction monitoring, annual reporting, and enforcement authority—including civil penalties and injunctions—for noncompliance, strengthening accountability and reducing the likelihood that approved transactions degrade care access or affordability over time.
HealthcareRef: Sec. 10(5), Sec. 14(2)-(3), Sec. 16
Potential Concerns (5)
Requires state review and potential denial of health care mergers/acquisitions that reduce access to care—including reproductive, gender-affirming, and end-of-life services—over a 5-year horizon, with explicit focus on equity for marginalized groups, potentially preventing harmful consolidations that have historically reduced service availability in underserved areas.
HealthcarePeopleRef: Sec. 9(1); Sec. 12(3)(a), (c), (f), (o)Mandates 5-year post-transaction monitoring, annual reporting, and enforcement authority—including civil penalties and injunctions—for noncompliance, strengthening accountability and reducing the likelihood that approved transactions degrade care access or affordability over time.
HealthcarePeopleRef: Sec. 10(5), Sec. 14(2)-(3), Sec. 16Requires at least one public hearing with multilingual notice, community engagement, and formal input from advocacy groups, employees, and public health experts—ensuring transparency and centering voices of impacted communities, especially those historically excluded from health system decision-making.
Public SafetyPeopleRef: Sec. 11(2)-(3); Sec. 12(1)Explicitly requires assessment of impacts on medically underserved populations—including Medicaid/Medicare beneficiaries, low-income, racial/ethnic minorities, LGBTQ+ individuals, people with disabilities, and terminally ill patients—and mandates evaluation of charity care, community benefit, and reduction of health disparities.
HealthcarePeopleRef: Sec. 9(2)(b)-(c); Sec. 12(3)(b), (d), (e), (h), (m)Provides streamlined review and simplified annual reporting for safety-net providers (e.g., FQHCs, rural clinics, providers serving ≥50% Medicaid/uninsured patients), reducing administrative burden on organizations most critical to equitable care access.
HealthcarePeopleRef: Sec. 4(2); Sec. 15
Who Is Most Affected
Large hospital systems and health networks will face increased regulatory burden, longer deal timelines, and potential deal rejection or conditioning—especially for transactions that reduce service access or equity. This may deter consolidation that would otherwise raise prices or reduce competition.
Rural clinics, FQHCs, and safety-net providers benefit from streamlined review and explicit inclusion in equity assessments, reducing administrative burden while ensuring their mission remains protected in consolidations.
Patients in rural areas, low-income communities, and marginalized groups (including LGBTQ+ and people of color) are likely to benefit from stronger protections against service reductions—especially for reproductive, gender-affirming, and end-of-life care—though outcomes depend on enforcement rigor.
State agencies (AG and HCA) gain significant new authority and resources (via fees and penalties), increasing their capacity to intervene in anti-competitive or inequitable transactions—but also expanding regulatory workload and potential legal challenges.
Health care workers may benefit from formal input rights during reviews and protections against staffing reductions, but could face uncertainty during prolonged review periods or if their employer’s transaction is blocked or conditioned.